➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Baxter
Boehringer Ingelheim
AstraZeneca
Express Scripts

Last Updated: October 26, 2020

DrugPatentWatch Database Preview

CYSTAGON Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Cystagon patents expire, and what generic alternatives are available?

Cystagon is a drug marketed by Mylan and is included in one NDA.

The generic ingredient in CYSTAGON is cysteamine bitartrate. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the cysteamine bitartrate profile page.

Drug patent expirations by year for CYSTAGON
Drug Prices for CYSTAGON

See drug prices for CYSTAGON

Recent Clinical Trials for CYSTAGON

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
NHS GrampianPhase 1/Phase 2
University of HuddersfieldPhase 1/Phase 2
Cystic Fibrosis TrustPhase 1/Phase 2

See all CYSTAGON clinical trials

Pharmacology for CYSTAGON

US Patents and Regulatory Information for CYSTAGON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan CYSTAGON cysteamine bitartrate CAPSULE;ORAL 020392-001 Aug 15, 1994 RX Yes No   Start Trial   Start Trial   Start Trial
Mylan CYSTAGON cysteamine bitartrate CAPSULE;ORAL 020392-002 Aug 15, 1994 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Colorcon
McKinsey
Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.